Given the physical and functional interactions between the BRCA1 and IGF1 signaling pathways, and to expand our previous studies on the transcriptional regulation of the IGF1R gene by BRCA1, we evaluated in the present study the impact of BRCA1 mutations on the ability to target the IGF1R in breast cancer cells. The gene discussed is BRCA1; the disease is breast carcinoma.